# P-244 Teclistamab versus Belgian real-world clinical practice in triple-class exposed relapsed and refractory multiple myeloma patients using adjusted comparison

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p-244-teclistamab-versus-belgian-real-world-clinical-practice-in-triple-class/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michel Delforge,Sébastien Anguille,Julien Depaus,Nathalie Meuleman,Ann Van de Velde,Isabelle Van de Broek,Joris Diels,Nichola Erler-Yates,Sébastien Van Causenbroeck,Kirsten van Nimwegen,Sophie Vandervennet,Susanne Lub,Marie-Christiane Madeleine Vekemans |
| Citations | 1 |
| DOI | 10.1016/s2152-2650(23)01862-1 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4387003705 |
| Type | conference-abstract |
| Year | 2023 |

## Paper authors

- [Kirsten van Nimwegen](https://scholariq.org/researchers/kirsten-van-nimwegen/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.